sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Point Of Care Molecular Testing For Infectious Diseases Market Scope And Analysis

  • Report Code : TIPRE00039163
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 162
Buy Now

North America Point-of-Care Molecular Testing for Infectious Diseases Market Scope and Analysis by 2031

Buy Now

North America Point-of-Care Molecular Testing for Infectious Diseases Market Report North America Point-of-Care Molecular Testing for Infectious Diseases Market Size and Share North America Point-of-Care Molecular Testing for Infectious Diseases Market Scope and Analysis

North America Point-of-Care Molecular Testing for Infectious Diseases Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1.09 billion
Market Size by 2031 US$ 2.62 billion
Global CAGR (2023 - 2031) 11.5%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Diseases
  • HIV Testing
  • Influenza Testing
  • Sexually Transmitted Diseases Testing
  • Hepatitis C Virus Testing
  • Tropical Diseases Testing
  • Respiratory Infection Testing
  • Hospital Acquired Infections
  • Strep
By Technology
  • Lateral Flow Assay
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Solid Phase
By Prescription Testing
  • Prescription Based Testing
  • OTC Testing
By Sample
  • Blood Sample
  • Urine Sample
  • Nasal and Oropharyngeal Swabs Sample
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Abbott Laboratories
  • Agilent Technologies Inc
  • Becton Dickinson and Co
  • Bio Rad Laboratories Inc
  • Cardinal Health Inc
  • Danaher Corp
  • Cue Health Inc
  • QuidelOrtho Corp
  • Thermo Fisher Scientific Inc
  • F Hoffmann La Roche Ltd